Notes:
- 1.
- This Chapter does not cover:
(a) Foods or beverages (such as dietetic, diabetic or fortified foods, food supplements, tonic beverages and mineral waters), other than nutritional preparations for intravenous administration (Section IV);
(b) Plasters specially calcined or finely ground for use in dentistry (heading No. 25.20);
(c) Aqueous distillates or aqueous solutions of essential oils, suitable for medicinal uses (heading No. 33.01);
(d) Preparations of heading Nos. 33.03 to 33.07 even if they have therapeutic or prophylactic properties;
(e) Soap or other products of heading No.34.01 containing added medicaments;
(f) Preparations with a bisis of plaster for use in dentistry (heading No. 34.07); or
(g) Blood albumin not prepared for therapeutic or prophylatic uses (heading No. 35.02).
- 2.
- For the purposes of heading No. 30.02, the expression "modified immunaological products" applies only to monoclonal antibodies (MABs), antibody fragments, antibody conjugates and antibody fragment conjugates.
- 3.
- For the purposes of heading Nos. 30.03 and 30.04 and of Note 4(d) to this Chapter, the following are to be treated:
(a) As unmixed products:
(1) Unmixed products dissolved in water;
(2) All goods of Chapter 28 or 29; and
(3) Simple vegetable extracts of heading No. 13.02, merely standardised or dissolved in any solvent;
(b) As products which have been mixed;
(1) Collodal solutions and suspensions (other than colloidal sulphur);
(2) Vegetable extracts obtained by the treatment of mixtures of vegetable materials; and
(3) Salts and concentrates obtained by evaporating natural mineral waters.
- 4.
- Heading No. 30.06 applies only to the following which are to be classified in that heading anc in no other heading of the Nomenclature:
(a) Sterile surgical catgut, similar sterile suture materials and sterile tissue adhesives for surgical wound closure;
(b) Sterile laminaria and sterile laminarial tents;
(c) Sterile absorbable surgical or dental haemostatics;
(d) Opacifying preparations for X-ray examinations and diagnostic reagents designed to be administered to the patient, being unmixed products put up in measured doses or products consisting of two more ingredients which have been mixed together for such uses;
(e) Blood-grouping reagents;
(f) Dental cements and other dental fillings, bone reconstruction cements;
(g) First-aid boxes and kits;
(h) Chemical contraceptive preparations based on hormones, on other products of heading 29.37 or on spermicides.
(ij) Gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments; and
(k) waste phrmaceuticals, that is, pharmaceutical products which are unfit for their original intended purpose due to, for example, expiry of shelf life.;
(Above Chapter has been amended vide BUDGET 2001-2002)